It has been shown that fisetin treatment in paralyzed patients suppresses the inflammatory response by reducing the production of inflammatory mediators (TNF-, IL-1, and NOS) and thus, prevents neuronal dysfunction and death by modulating the activity of inducers that trigger neurodegenerative mechanisms [60]
It enhances white blood cell activity, supports the production of antibodies and helps regulate inflammation, allowing the body to fight infections and illnesses
Ipamorelin peptide was designed to act via ghrelin receptor binding
Secondary searches were performed using Google Scholar and regulatory sources, e.g., US Food and Drug Administration (FDA) labels and European Medicines Agency (EMA) reports, to capture gray literature and pharmacovigilance data
Tb-500 reduces inflammation through microRNA-146a upregulation while Bpc-157 works via erg-1 transcription factor inhibition
PMCID: PMC13214175